Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950123-09-004205
Filing Date
2009-03-06
Accepted
2009-03-06 16:22:32
Documents
5
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q y01269e10vqza.htm 10-Q/A 260750
2 EX-31.1: CERTIFICATION y01269exv31w1.htm EX-31.1 8787
3 EX-31.2: CERTIFICATION y01269exv31w2.htm EX-31.2 8774
4 EX-32.1: CERTIFICATION y01269exv32w1.htm EX-32.1 3343
5 EX-32.2: CERTIFICATION y01269exv32w2.htm EX-32.2 3352
  Complete submission text file 0000950123-09-004205.txt   286667
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33357 | Film No.: 09663131
SIC: 2836 Biological Products, (No Diagnostic Substances)